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Background: Liver cancer comprises a group of malignant tumors, among which 
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the 
most common. ICC is especially pernicious and associated with poor clinical outcome. 
Studies have shown that a subset of human ICCs may originate from mature 
hepatocytes. However, the mechanisms driving the trans-differentiation of hepatocytes 
to malignant cholangiocytes remain poorly defined. Methods: We adopted lineage 
tracing techniques and established murine hepatocyte derived ICC models by 
hydrodynamic injection of activated forms of AKT (myr-AKT) and Yap (YapS127A) 
proto-oncogenes. Wild-type, Notch1flox/flox and Notch2flox/flox mice were used to 
investigate the role of canonical Notch signaling and Notch receptors in AKT/Yap driven 
ICC formation. Human ICC and HCC cell lines were transfected with siRNA against 
Notch2 to study whether Notch2 regulates biliary marker expression in liver tumor cells. 
Results: We confirmed that AKT/Yap induced ICC formation is hepatocyte derived and 
this process is strictly dependent on the canonical Notch signaling pathway in vivo. 
Deletion of Notch2 in AKT/Yap induced tumors switched the phenotype from ICC to 
hepatocellular adenoma-like lesions, while inactivation of Notch1 in hepatocytes did not 
result in significant morphological changes. Finally, in vitro studies revealed that Notch2 
silencing in ICC and HCC cell lines down-regulates the expression of Sox9 and EpCAM 
biliary markers. Conclusion: Notch2 is the major determinant of hepatocyte derived 
ICC formation in mice. 
